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inhibitory interneurons that express GFP in the
PrP-GFP mouse
Noboru Iwagaki†, Francesca Garzillo†, Erika Polgár, John S Riddell* and Andrew J Todd*Abstract
Background: Inhibitory interneurons in the superficial dorsal horn play important roles in modulating sensory
transmission, and these roles are thought to be performed by distinct functional populations. We have identified 4
non-overlapping classes among the inhibitory interneurons in the rat, defined by the presence of galanin,
neuropeptide Y, neuronal nitric oxide synthase (nNOS) and parvalbumin. The somatostatin receptor sst2A is
expressed by ~50% of the inhibitory interneurons in this region, and is particularly associated with nNOS- and
galanin-expressing cells. The main aim of the present study was to test whether a genetically-defined population of
inhibitory interneurons, those expressing green fluorescent protein (GFP) in the PrP-GFP mouse, belonged to one or
more of the neurochemical classes identified in the rat.
Results: The expression of sst2A and its relation to other neurochemical markers in the mouse was similar to that in
the rat, except that a significant number of cells co-expressed nNOS and galanin. The PrP-GFP cells were entirely
contained within the set of inhibitory interneurons that possessed sst2A receptors, and virtually all expressed nNOS
and/or galanin. GFP was present in ~3-4% of neurons in the superficial dorsal horn, corresponding to ~16% of the
inhibitory interneurons in this region. Consistent with their sst2A-immunoreactivity, all of the GFP cells were
hyperpolarised by somatostatin, and this was prevented by administration of a selective sst2 receptor antagonist or
a blocker of G-protein-coupled inwardly rectifying K+ channels.
Conclusions: These findings support the view that neurochemistry provides a valuable way of classifying inhibitory
interneurons in the superficial laminae. Together with previous evidence that the PrP-GFP cells form a relatively
homogeneous population in terms of their physiological properties, they suggest that these neurons have specific
roles in processing sensory information in the dorsal horn.Background
Lamina II of the spinal dorsal horn contains numerous
densely-packed interneurons, which are involved in
transmitting and modulating somatosensory information
before it is conveyed to the brain (through projection
neurons located in other laminae) and to deeper regions
of the spinal cord [1]. Quantitative immunocytochemical
studies in rat and mouse have suggested that approxi-
mately 30% of the interneurons in this lamina are
GABAergic, with some using glycine as a co-transmitter
[2-4], and these are thought to play an important role in* Correspondence: John.Riddell@glasgow.ac.uk; Andrew.Todd@glasgow.ac.uk
†Equal contributors
Institute of Neuroscience and Psychology, College of Medical, Veterinary and
Life Sciences, University of Glasgow, Glasgow G12 8QQ, UK
© 2013 Iwagaki et al.; licensee BioMed Centra
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
waiver (http://creativecommons.org/publicdom
stated.suppressing pain and itch [5-8]. Numerous attempts
have been made to identify distinct functional popula-
tions among the interneurons in this region, based on
their morphological, physiological and neurochemical
properties, or their developmental lineage [9-28]. The
most widely accepted scheme is that developed by Grudt
and Perl [11], which recognises four major classes of
lamina II interneuron, defined mainly by their somatoden-
dritic morphology: islet, vertical, central and radial cells. It
has been shown that islet cells are inhibitory, while most
vertical and radial cells are excitatory [14,15,19,20,29].
However, although these cell types have been recognised
in other studies, a significant proportion of the lamina II
neurons cannot be unequivocally assigned to any of these
classes [11,12,14,15,23,30].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
Table 1 Antibodies used in this study
Antibody Species Dilution Source
GABA rabbit 1:5,000 DV Pow
sst2A guinea pig 1:2,000 Gramsch laboratories
GFP mouse 1:100 Synaptic Systems
nNOS sheep 1:2,000 PC Emson
Galanin rabbit 1:1,000 Bachem
NPY rabbit 1:1,000 Bachem
Parvalbumin goat 1:500 Swant
Parvalbumin rabbit 1:500 M Watanabe
NeuN mouse 1:500 Millipore
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classifying neurons, and we have identified four non-
overlapping populations of dorsal horn inhibitory inter-
neurons that express neuropeptide Y (NPY), galanin,
neuronal nitric oxide synthase (nNOS) or parvalbumin,
in the rat [17,31]. The somatostatin receptor sst2A is
restricted to GABAergic neurons in the superficial
laminae, and is expressed by around half of these cells
[4,13,14,32]. We have recently found that in the rat,
most of the galanin and nNOS-expressing inhibitory in-
terneurons showed sst2A-immunoreactivity, while this
was present on only 16% of the NPY cells and virtually
none of those with parvalbumin [13]. This suggests that
the receptor is associated with specific functional classes
of inhibitory interneuron. However, little is yet known
about the relationship between these neurochemical
populations in the mouse, which is now widely used
in pain research, due to the availability of genetically
modified lines.
Several recent studies have used mice in which fluor-
escent proteins are expressed in subsets of interneurons,
in order to target these for whole cell patch-clamp re-
cording [12,33-40]. One of these lines is the PrP-GFP
mouse, in which enhanced green fluorescent protein
(GFP) is expressed under control of the prion pro-
moter [34,35,40,41]. GFP expression in the spinal cord
of this mouse is largely restricted to lamina II, where it
labels a set of inhibitory interneurons [35]. These cells
form a physiologically homogeneous population, and
show consistent features in terms of their synaptic inputs
and outputs [34,35,40]. However, little is known about
their expression of the neurochemical markers that have
been identified in inhibitory interneurons, apart from the
fact that they do not contain parvalbumin [34].
The initial aims of this study were to test whether
the pattern of expression of sst2A by cells that contained
galanin, nNOS, NPY or parvalbumin was the same in
the mouse as reported for the rat [13], and to determine
whether the PrP-GFP cells corresponded to one or more
of these neurochemical populations. Since we found
that all of the PrP-GFP cells expressed sst2A receptors,
we went on to characterise their responses to somato-
statin, specifically testing whether these were mediated
by sst2 receptors. We also looked for involvement of
G-protein-coupled inwardly rectifying K+ (GIRK) channels,
which are thought to be activated by somatostatin in lamina
II neurons [42].
Methods
All animal experiments were approved by the Ethical
Review Process Applications Panel of the University of
Glasgow, and were performed in accordance with the
European Community directive 86/609/EC and the UK
Animals (Scientific Procedures) Act 1986.Neurochemistry of inhibitory interneurons
Animals
Nine PrP-GFP mice [41] of either sex (6–10 week old;
University of Glasgow Biological Services) and 3 male
NIHS mice (32-34 g; Harlan UK; closely related to the
Swiss-Webster strain from which the PrP-GFP line was
derived) were deeply anaesthetised with pentobarbitone
(30 mg i.p.) and perfused through the left ventricle with
fixative. For the PrP-GFP mice this contained 4% freshly
de-polymerised formaldehyde, while for the NIHS mice
it contained 4% formaldehyde/0.2% glutaraldehyde. The
glutaraldehyde-containing fixative was used to maximise
retention of GABA [43,44].
General features of tissue processing, confocal microscopy
and analysis
Following perfusion fixation, the lumbar spinal cord was
removed from all animals and the L4 segment was cut
into transverse sections 60 μm thick with a vibrating
microtome. All sections were immersed in 50% ethanol
for 30 mins, and those from glutaraldehyde-fixed animals
were treated with 1% sodium borohydride for 30 mins
(to reduce free aldehyde groups), followed by extensive
rinsing. Sections were then processed for multiple-
labelling immunofluorescent detection, as described
below. Details of the sources and concentrations of
primary antibodies are given in Table 1. All secondary
antibodies were raised in donkey and were species-specific.
Secondary antibodies were conjugated to Rhodamine Red,
DyLight 649 (1:100, 1:500, respectively; both from Jackson
Immunoresearch, West Grove, PA, USA), or Alexa 488
(1:500; Life Technologies, Paisley, UK). In some cases,
biotinylated secondary antibodies (1:500; Jackson Immu-
noresearch) were used, and these were revealed with avidin
conjugated to Pacific Blue (1:1,000; Life Technologies).
Primary antibody incubations were for 3 days and those
in secondary antibodies were overnight (both at 4°C).
Antibodies were diluted in PBS that contained 0.3%
Triton-X100, except for reactions involving anti-sst2A,
in which 5% normal donkey serum was included in both
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from the PrP-GFP mice that were used to estimate the
percentage of neurons with GFP were incubated in
propidium iodide as a nuclear counterstain following
the immunoreaction [32]. All sections were mounted
in anti-fade medium and stored at −20°C.
To avoid observer bias, sections were selected for con-
focal scanning and analysis before immunofluorescence
was examined. They were scanned with a Zeiss LSM710
confocal microscope (with Argon multi-line, 405 nm diode,
561 nm solid state and 633 nm HeNe lasers) through a
40× oil-immersion lens (numerical aperture 1.3) with the
pin-hole set to 1 Airy unit. Overlapping fields to cover the
whole of laminae I-III were scanned at 2 μm z-separation
through the full thickness of the section, except for the
analysis of GABA immunoreactivity and for the counts of
GFP+ neurons (see below).
All quantitative analyses were carried out with
Neurolucida for Confocal software (MBF Bioscience;
Williston, VT, USA). The outline of the grey matter
and the border between laminae II and III were drawn for
the transverse sections, and the locations of immunoreac-
tive cells were plotted onto these outlines. The position of
the lamina II/III border was determined either from dark
field scans, or from the ventral border of the plexus of
sst2A-immunoreactive dendrites [4,32]. In some cases the
lamina I/II border, identified in dark field scans, was also
included. A stereological method was used to determine
the proportion of superficial dorsal horn neurons that
were GFP-positive (see below), but not for any of the ana-
lyses of cell counts in the z-stacks that were obtained from
the full thickness of the sections. However, the sampling
bias towards larger neurons in these analyses is likely to
have been very small, as the section thickness (60 μm) was
considerably larger than the cell bodies of the neurons
that were being sampled.
GABA, sst2A and nNOS
We have recently demonstrated that sst2A is restricted to
GABA-immunoreactive neurons in laminae I-II of C57Bl/
6 mice [4]. To confirm that this arrangement applied to
NIHS mice (which are closely related to the PrP-GFP line)
and to assess the extent of sst2A expression among nNOS-
containing inhibitory interneurons, we reacted sections
from the 3 NIHS mice with rabbit anti-GABA, guinea pig
anti-sst2A and sheep anti-nNOS, and revealed these with
fluorescent secondary antibodies.
The relationship between sst2A and GABA was exam-
ined in 4 dorsal horns from each of 3 mice. Since pene-
tration of GABA immunostaining is extremely limited in
sections that have been reacted by this method [4,45,46],
only the upper surface of the section was scanned, at
0.5 μm z-separation. Overlapping z-stacks to cover the
whole of laminae I-III were obtained. All sst2A
+ cells inlaminae I-III that were present at the section surface (i.e. on
the first optical section in the z-series that contained tissue)
were initially identified and plotted onto a dorsal horn
outline, and these cells were then examined for the
presence of GABA-immunoreactivity.
Since nNOS is expressed by both inhibitory and excita-
tory interneurons [45], we used these sections to determine
the proportion of inhibitory (GABA-immunoreactive)
nNOS+ neurons that possessed sst2A receptors. For this
part of the study, 8 dorsal horns from each mouse were
analysed, in order to provide a sufficient sample size. All
nNOS+/GABA+ cells with nuclei at the section surface
were identified and their locations were plotted. The
presence or absence of sst2A was then assessed for each
of the selected cells.
Neurochemical markers in PrP-GFP mice and their expression
by GFP+ cells
Sections from the PrP-GFP mice were used to analyse:
(i) the expression of sst2A by neurons immunoreactive
for galanin, NPY or parvalbumin, (ii) expression of sst2A
by GFP+ neurons, (iii) the presence of nNOS, galanin, NPY
or parvalbumin in GFP+ neurons, and (iv) the relation-
ship between galanin and nNOS in sst2A
+ (inhibitory)
interneurons. The sections were reacted with mouse
anti-GFP and guinea pig anti-sst2A, together with either
(i) rabbit anti-galanin and sheep anti-nNOS, (ii) rabbit
anti-NPY (in some cases combined with goat anti-
parvalbumin), or (iii) rabbit anti-parvalbumin. These
were revealed with appropriate fluorescent secondary
antibodies. From each of four mice, we scanned four
dorsal horns that had been reacted with the galanin/nNOS
antibody combination, and four dorsal horns reacted for
NPY and parvalbumin.
To investigate expression of sst2A among the different
neurochemical populations, all cells in laminae I-III that
were immunoreactive for galanin, NPY or parvalbumin
were plotted, and then the sst2A channel was viewed and
the presence or absence of the receptor was noted for each
of these neurons. Expression of sst2A by GFP
+ cells was
analysed in 5 mice (4–8 dorsal horns from each mouse).
The GFP channel was initially viewed and the locations
of all GFP+ cells in laminae I-II were plotted. The sst2A
channel was then examined and the presence or absence
of sst2A staining was noted for each of the GFP
+ cells.
To determine whether GFP+ cells contained nNOS,
galanin, NPY or parvalbumin, we looked for the pres-
ence of these types of immunoreactivity in all of the
GFP+ cells identified in 4 dorsal horns from each of 4
mice for each neurochemical type.
During this part of the study, we observed that unlike
the situation in the rat [31], there was significant coex-
istence of galanin and nNOS in sst2A-expressing neu-
rons in laminae I-II. However, cells that were strongly
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for nNOS, and vice versa. We therefore analysed this
coexistence quantitatively in two of the dorsal horns
from each of four mice. To do this, the sst2A and galanin
channels were viewed, and all of the sst2A-expressing
cells were identified. All of the cells that were galanin-
immunoreactive were then assigned a score for the
intensity of galanin-immunoreactivity, ranging from 4
(very strong) to 1 (weak) or 0 (negative). The sections
were then re-examined, in this case with the channels for
sst2A and nNOS, and sst2A
+ cells that were nNOS immuno-
reactive were assigned a score of 4 (very strong) to 1 (weak)
or 0 (negative) to indicate the intensity of the nNOS
immunoreactivity. The resulting Neurolucida files were
then combined to reveal the strength of galanin and
nNOS immunostaining for each of the cells that con-
tained either or both of these substances.
Many of the cells with galanin and/or nNOS were found
to be GFP+, and the intensity of GFP expression differed
among these neurochemical groups. We therefore recorded
the strength of GFP immunoreactivity in all GFP+ cells
identified in these sections and related this to the pattern of
galanin and nNOS expression. As before, we assigned a
score of 4 (very strong) to 1 (weak) for GFP. This was done
by an observer who was blind to the strength of galanin or
nNOS immunoreactivity in these cells. As reported previ-
ously [35], occasional GFP+ cells were found below lamina
II, but these were not included in any of the analyses.
Proportion of superficial dorsal horn neurons with GFP in
PrP-GFP mice
In order to estimate the proportion of superficial dorsal
horn neurons that were GFP+, we examined sections
from 3 PrP-GFP mice that had been reacted with mouse
anti-GFP, and then with NeuN antibody (revealed with
Alexa 488 and DyLight 649, respectively), followed by
propidium iodide. Four dorsal horns from each of these
animals were scanned to produce z-series of 24 optical
sections at 1 μm z-separation. These were analysed by
using a modification of the optical disector method [32] as
described in detail by Polgár et al. [47].
Characterisation of antibodies
The GABA antibody was raised against GABA conju-
gated to porcine thyroglobulin with glutaraldehyde, and
shows negligible cross-reactivity against other amino
acids (glutamate, aspartate, glycine or taurine) [48]. The
sst2A antibody was raised against the C terminal 15
amino acids of the peptide sequence of the rat and
mouse sst2A receptor, coupled to keyhole limpet haemo-
cyanin. Immunostaining was blocked by incubation with
the peptide antigen (manufacturer’s specification). The
GFP antibody was raised against recombinant GFP, and
the distribution of immunostaining matched that ofcells that expressed GFP. The nNOS antibody labels a
band of 155 kDa in Western blots of rat hypothalamus,
and staining is abolished by pre-incubation with nNOS
[49]. We have reported that dorsal horn immunostain-
ing with the galanin and NPY antibodies can be abol-
ished by pre-treatment with the corresponding peptides
[50,51], and staining of neurons with the galanin antibody
is absent from the brains of galanin knock-out mice [52].
The rabbit and goat parvalbumin antibodies were raised
against mouse and rat parvalbumin, respectively, and rec-
ognise a protein band of the appropriate size on Western
blots. The NeuN antibody was raised against cell nuclei
extracted from mouse brain and found to react with a pro-
tein specific for neurons [53]. We have shown that NeuN
labels all neurons but does not label glial cells in the rat
spinal dorsal horn [32].
Responses of PrP-GFP cells to somatostatin
Young adult (4–6 week old) PrP-GFP mice (University
of Glasgow Biological Services) were anaesthetised with
continuous inhalation of 1-3% isoflurane. After laminec-
tomy, the mid-thoracic to sacral spinal cord was removed
and transferred to ice-cold dissecting solution containing:
(mM) 3.0 KCl, 1.2 NaH2PO4, 2.4 CaCl2, 1.3 MgCl2, 26.0
NaHCO3, 15.0 glucose, 251.6 sucrose, oxygenated with
95% O2 and 5% CO2. The mouse was killed by anaesthetic
overdose and decapitation. The dura and pia mater were
removed, together with all dorsal and ventral roots. The
isolated spinal cord was placed on an agar block positioned
on a vibrating blade microtome (Microm HM 650 V,
Fisher Scientific, Loughborough, UK). Parasagittal slices
(200–300 μm) were cut, and these were subsequently
kept for at least 30 min in recording solution contain-
ing: (mM) 125.8 NaCl, 3.0 KCl, 1.2 NaH2PO4, 2.4 CaCl2,
1.3 MgCl2, 26.0 NaHCO3, 15.0 glucose, oxygenated with
95% O2 and 5% CO2.
Slices were transferred to a recording chamber per-
fused with the oxygenated recording solution (flow
rate ~2 ml/min) at room temperature. Whole-cell patch-
clamp recordings were made from GFP-positive neurons.
The targeted cells were visualised under infrared differential
interference contrast and fluorescence microscopy on
an Olympus BX51WI microscope. Patch electrodes were
pulled with a horizontal puller (Sutter Instrument, Novato,
CA, USA) from thin wall glass capillaries (World Precision
Instruments, Sarasota, FL, USA). The electrode was filled
with internal solution containing: (mM) 130 potassium
gluconate, 10 KCl, 2 MgCl2, 10 HEPES, 0.5 EGTA, 2
ATP-Na2, 0.5 GTP-Na, pH adjusted to 7.3 with 1 M
KOH. Neurobiotin (0.2%, Life Technologies) was also
included in the internal solution for morphological analysis
of recorded cells (to be reported subsequently). Typical
electrical resistance of solution-filled electrodes was 4–6
MΩ. Patch-clamp signals were amplified and filtered
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amplifier (Molecular Devices, Sunnyvale, CA, USA) and
acquired at 10 kHz using a Digidata 1440 A A/D board
and pClamp 10 software (Molecular Devices). Acquired
data were analysed using pClamp 10 software, and data
are reported as mean ± SEM.
Drugs were bath-applied via 3-way stopcocks without
any change in perfusion rate or temperature. They were
purchased as follows: somatostatin (Merck Chemicals,
Nottingham, UK), CYN 154806 (Tocris Bioscience, Bristol,
UK), and tertiapin-Q (Abcam, Cambridge, UK).
Although the mice used for electrophysiology were
slightly younger than the PrP-GFP mice in the anatomical
part of the study, this should have no effect on the re-
sponses to somatostatin, as we have found that the pattern
of sst2A expression is already established within the first
postnatal week in mice (AJT and EP, unpublished data).
Statistical tests
Spearman’s rank correlation test was used to investigate
the relationship between galanin and nNOS staining in-
tensity among sst2A-expressing cells in the PrP-GFP mice,
and Student’s t-test for electrophysiological data. P values
of < 0.05 were taken as significant.
Results
Neurochemistry of interneuron populations
The distribution of immunostaining for nNOS, galanin,
NPY, parvalbumin, sst2A and GABA in the mouse spinal
cord was very similar to that seen in the rat, although as re-
ported by Hughes et al. [36], parvalbumin-immunoreactive
lamina III cells were more numerous than in the rat.
Between 104 and 132 (mean 118) sst2A
+ cells were
identified in laminae I-II in the sections from the 3
glutaraldehyde-fixed mice, and all but one of these
cells (99.7%) were GABA-immunoreactive (Figure 1).
Fourteen sst2A
+ cells (mean 4.7/mouse) were present in
lamina III in the sections analysed, and 10 of these
(mean 67.5%) were GABA-immunoreactive.
The relationship of sst2A to galanin, nNOS/GABA, NPY
and parvalbumin in the mouse was generally very similar
to what we have reported previously in the rat [13]Figure 1 nNOS, GABA and sst2A in lamina II in the mouse. A single con
GABA and sst2A. A nNOS
+/GABA+ neuron (double arrow) is sst2A
+ . Several ot
that are sst2A
+ are marked with arrows, while two that are sst2A
- are indicate
asterisks. Scale bar: 20 μm.(Table 2, Figure 1, Figure 2). In laminae I-II, sst2A was
expressed by virtually all galanin+ and most (95%)
nNOS+/GABA+ cells, but only by 24% of NPY+ cells
and no parvalbumin+ cells. In lamina III, the receptor
was expressed by 42% of the nNOS+/GABA+ cells and
by a few galanin cells.
Since GABA immunostaining could only be assessed
at the top surface of the sections, there could be a sam-
pling bias towards larger cells in this part of the analysis.
However, since GABA was detected in 99.7% of sst2A
cells in laminae I-II, while 95% of GABA+/nNOS+ cells
in this region were sst2A-immunoreactive, sampling bias
is unlikely to have affected our interpretation.
As stated above, there was some coexistence of galanin
and nNOS expression among sst2A
+ cells in laminae I-II
in the mouse (Figure 2a-e), unlike the situation in the rat
[31]. Among the sst2A cells, 17% (range 14-18%, n = 4 mice)
were nNOS+/galanin-, 31% (24-36%) were nNOS-/galanin+,
13% (10-17%) were nNOS+/galanin+, while 39% (36-44%)
contained neither galanin nor nNOS (Figure 3). The
strength of immunostaining for nNOS and galanin
among the sst2A
+ cells that expressed one or both of
these markers is shown in Figure 4a. There was a clear
inverse relationship between the staining intensity for
each marker (RS = −0.76, P < 0.001, Spearman’s rank
order correlation test).
GFP neurons in the PrP-GFP mouse
In the PrP-GFP mouse, many GFP+ cells were present in
the dorsal horn and these were largely restricted to lamina
II, with occasional cells in laminae I and III, as reported
previously [34,35,40]. Altogether, 1133 GFP+ neurons in the
superficial dorsal horn (laminae I and II) were examined in
sections from 5 mice (133–302 neurons per mouse) and
all but one of these cells (99.9%, range 99.7-100%) were
sst2A
+ (Figure 2).
We next examined the expression of GFP among the
different neurochemical populations. In the sections
reacted for GFP, sst2A, galanin and nNOS, 98% (range
97-99%, n = 4 mice) of the GFP cells were nNOS- and/
or galanin-immunoreactive (Figures 2a-j). Specifically,
35% (23-41%) were nNOS+/galanin-, 28% (23-33%) werefocal scan through a section that had been reacted to reveal nNOS,
her GABA+ cells that lack nNOS are present in this field. Two of these
d with arrowheads. Three nearby GABA-negative cells are labelled with
Table 2 Expression of sst2A by different neurochemical
types of interneuron in the mouse dorsal horn
Laminae I + II Lamina III
Number
counted
% sst2A Number
counted
% sst2A
nNOS/GABA 62.7 94.9 8.3 42.1
(56–67) (91–98.2) (6–12) (33.3-50)
Galanin 202.3 99.8 3 10.4
(194–219) (99.5-100) (1–6) (0–25)
NPY 95.6 24.2 28.5 4.1
(73–109) (17.4-31.5) (21–34) (0–6.9)
Parvalbumin 18.8 0 162.8 0
(15–25) (144–183)
In each case the mean values for 3 NIHS mice (nNOS/GABA) or 4 PrP-GFP mice
(galanin, NPY, parvalbumin) are shown, with the range in brackets.
Figure 2 GFP and sst2A expression among different neurochemical
interneuron populations in the PrP-GFP mouse. a-e, a field from
lamina II contains three GFP-labelled neurons, all of which are sst2A
+ . The
cells numbered 1 and 3 show weak immunoreactivity for both nNOS
and galanin, while the cell numbered 2 is strongly nNOS+ and galanin-.
f-j, a nearby region from the same section includes a cell with weak GFP
(arrow) that is sst2A
+ and shows strong galanin immunoreactivity, but lacks
nNOS. k-o, This field from lamina II includes a GFP cell (arrow) that is sst2A
+
but does not contain NPY or parvalbumin (PV). Two nearby cells are
indicated with arrowheads. The one on the left is PV+/NPY-, while the
one on the right is PV-/NPY+. Both of these cells lack sst2A. Scale
bar (in o): 20 μm.
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In contrast, none of the GFP+ cells that were seen in the
sections reacted for NPY or parvalbumin contained either
of these markers (Figure 2k-o), consistent with the finding
by Hantman and Perl [34] that the GFP cells are different
from those that contain parvalbumin.
The relationship between GFP, galanin, nNOS and
sst2A was analysed in detail in 2 dorsal horns each from
4 mice (selected from the sections used to investigate
coexistence of galanin and nNOS). The GFP cells consti-
tuted 28.8% (25.5-31.2%) of all sst2A neurons in laminae I
and II. When considering the different sub-populations
of sst2A-expressing neurons, GFP cells accounted for
23% (15.9-33.3%) of those that contained galanin but
not nNOS, 57% (44.4-67.4%) of those that contained
nNOS but not galanin, 83% (66.7-90.7%) of the cells that
contained both nNOS and galanin, and 4% (1.9-6%) of
those that contained neither (Figure 3, Figure 4b). GFP
was expressed by 69.2% (62.1-73.5) of all nNOS+/sst2A
+
cells and by 41% (27.4-57.3) of all galanin+/sst2A
+ cells in
laminae I-II.
The intensity of GFP labelling varied considerably
among these cells, and this was related to their expression
pattern for galanin and nNOS, and also to their location
within lamina II (Figure 5). To simplify this part of the
analysis, we divided the cells into 3 groups: those that
were galanin+/nNOS-, or for which the galanin intensity
score was higher than that for nNOS (galanin group),
those that were galanin-/nNOS+ or for which the
nNOS intensity score was higher than that for galanin
(nNOS group) and the few cells for which the intensity
scores for galanin and nNOS were equal ("both" group).
As can be seen from Figure 5, cells belonging to the
galanin group tended to have a lower intensity of GFP
and to be located dorsally, while those in the nNOS
group generally showed stronger GFP labelling and were
located more ventrally within lamina II.In the sections reacted with anti-GFP, NeuN and propi-
dium iodide, between 676 and 756 (mean 710) neurons in
laminae I and II were included in the disector sample from
the 3 mice, and 3.4% (3.3-3.7%) of these were GFP+. When
laminae I and II were analysed separately, between 71–88
neurons in lamina I were included and none of these were
GFP+, while for lamina II 590–668 (mean 628) neurons
were included in the sample and 3.9% (3.7-4.2%) of these
were GFP+. This result is consistent with our finding
that ~29% of sst2A
+ neurons in laminae I-II contain GFP,
and that sst2A
+ cells account for ~14% of all neurons in
laminae I-II in C57Bl/6 mice [4]. It is somewhat lower
Figure 3 Expression of galanin and nNOS among sst2A
+ neurons
in the superficial dorsal horn, and their relationship with GFP
in the PrP-GFP mouse. The pie chart shows the sizes of different
neurochemical populations among the inhibitory interneurons in
laminae I-II. We have estimated that 54% of the inhibitory interneurons
in this region are sst2A-immunoreactive in a different mouse strain
(C57Bl/6) [4], and the present results indicate that the proportion of
these cells that contain only nNOS, only galanin or both nNOS and
galanin are 17%, 31% and 13%, respectively. The proportions of each
of these populations that are accounted for by GFP+ neurons in the
PrP-GFP mouse are shown in green, with the corresponding
percentages indicated.
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II neurons were GFP+, and this discrepancy may have
arisen because these authors did not use a stereological
method. Since we have previously estimated that 24.2% of
lamina II neurons are GABAergic in C57Bl/6 mice [4], the
GFP cells are likely to account for ~16% of the inhibitory
interneurons in this lamina.Figure 4 Strength of immunostaining for nNOS and galanin among s
The frequency of cells with different intensities of labelling for nNOS and g
were pooled from 4 mice (two dorsal horns from each mouse). Although m
showed both types of immunoreactivity. b, The equivalent frequency histoResponses of PrP-GFP neurons to somatostatin
Whole-cell patch-clamp recordings were performed on
17 PrP-GFP cells in lamina II. Brief subthreshold voltage
steps (100 ms, -70 to −50 mV, 2.5 mV increments) were
applied from a holding potential of −60 mV to establish
the current–voltage (I-V) relationship of the recorded
cells. The resting membrane potential and input resistance
of each cell were determined from the I-V relationship. The
mean resting membrane potential was −54.3 ± 2.5 mV and
the input resistance was 796.6 ± 106.4 MΩ (n = 17). In
current-clamp mode, each cell was injected with suprathres-
hold square-wave current pulses (1 s duration) to character-
ise its firing pattern. All of the cells were able to produce
action potentials repetitively. Most (16/17) showed tonic
firing, as reported previously [35], while the remaining cell
was defined as an initial burst firing cell [10,54].
Since all of the PrP-GFP cells were found to show
sst2A-immunoreactivity, their response to bath-applied
somatostatin was investigated. Application of somato-
statin (2 μM) caused strong hyperpolarisation in all 7
PrP-GFP neurons tested (mean 8.9 ± 2.8 mV) (Figure 6a,b),
which was statistically significant (p < 0.05) (Figure 6b).
To assess the receptor subtype that mediated this
somatostatin-evoked hyperpolarisation, a specific sst2
receptor antagonist, CYN 154806 (1 μM), was applied
prior to and during application of somatostatin (2 μM)
on a further 5 cells. In the presence of CYN 154806,
the application of somatostatin did not change resting
membrane potential in any of these cells (Figure 6c),st2A
+ and GFP+ neurons in laminae I-II of the PrP-GFP mouse. a,
alanin, graded from 4 (strong) to 1 (very weak), or 0 (negative). Data
any cells were only immunoreactive for nNOS or galanin, some
gram for all of the cells shown in a that were also GFP-labelled.
Figure 5 GFP intensity among galanin and nNOS cells in the superficial dorsal horn of the PrP-GFP mouse and their laminar distribution.
The GFP+ cells that contained either galanin or nNOS were divided into 3 groups: those that had a higher intensity score for galanin (galanin), those
with a higher score for nNOS (nNOS) and those for which the scores were equal (both). a The numbers of cells belonging to each group that were
defined as having weak (1), medium (2), strong (3) or very strong (4) labelling for GFP. Each column shows the mean number of cells per mouse and
the range across the 4 mice. Note that cells in the galanin group tended to have a low level of GFP, while those in the nNOS group often had high
GFP levels. b The laminar location of cells in these 3 groups plotted onto an outline of the superficial dorsal horn. In each drawing the upper line
represents the edge of the dorsal horn and the lower line the lamina II-III border. Cells belonging to the nNOS group are shown as open circles, those
in the galanin group as filled circles and those defined as both as filled triangles. The lower right drawing shows all 3 groups combined.
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hyperpolarisation.
To investigate the ionic current responsible for the
somatostatin-evoked hyperpolarisation, the I-V relation-
ship for somatostatin-evoked current was generated by
subtracting the I-V plot obtained in the control recording
solution from that obtained in the presence of somatostatin
(n = 7, Figure 6d,e). Fitting a linear regression model,
the reversal potential of this somatostatin current was
approximately −90 mV, which is close to the K+equilibrium potential (−97 mV) calculated by the
Nernst equation (Figure 6e). Since it has been reported
that the somatostatin-evoked hyperpolarising current is
mediated by inwardly rectifying K+ channels [42,55,56],
we next investigated whether GIRK channels were acti-
vated during somatostatin application. Following bath-
application of the GIRK channel antagonist tertiapin-Q
(0.5 μM), somatostatin (2 μM) did not alter resting mem-
brane potentials in any of the 5 PrP-GFP cells tested
(Figure 6f ). Taken together, these results suggest that
Figure 6 The effect of somatostatin in PrP-GFP neurons. a An example trace showing the membrane hyperpolarisation in response to
somatostatin application. b The membrane potential before (control) and during somatostatin application. The mean hyperpolarisation was 8.9 ±
2.8 mV, and this was statistically significant (p < 0.05, n = 7). c The membrane potential did not change when somatostatin was applied in the
presence of the sst2 receptor antagonist, CYN 154806 (n = 5). d Currents measured in response to brief voltage steps (100 ms, −70 to −50 mV) in
control and somatostatin conditions. e The current–voltage (I-V) relationship for the somatostatin-evoked current (n = 7). The reversal potential of
this current is approximately −90 mV. f The membrane potential did not change when somatostatin was applied in the presence of the GIRK
channel blocker, tertiapin-Q (n = 5), suggesting that the somatostatin-mediated membrane hyperpolarisation in the PrP-GFP cells involves
activation of GIRK channels.
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coupled to the activation of GIRK channels, to produce
a significant membrane hyperpolarisation of PrP-GFP
neurons.
Discussion
The main findings of this study are that: (1) sst2A is re-
stricted to inhibitory interneurons in mouse superficial
dorsal horn and that its expression among neurochem-
ical subpopulations is similar to that reported in rat [13];
(2) unlike the situation in the rat [31], there is some co-
existence of nNOS and galanin in superficial dorsal horn
neurons in mouse; (3) all GFP cells in lamina II of the
PrP-GFP mouse possess sst2A receptors, and virtually all
express nNOS and/or galanin; and (4) the GFP cells are
all hyperpolarised by somatostatin, an effect that is pre-
vented by application of a specific sst2 receptor antagon-
ist or a GIRK-channel blocker.
Neurochemical populations of interneurons in the mouse
It is important to identify distinct populations among
the inhibitory interneurons in the superficial dorsal horn,as these are likely to have specific functions, for example
preventing different types of pain [7], suppressing itch [6],
or regulating other sensory inputs [36]. We have previ-
ously identified 4 non-overlapping populations among the
GABAergic neurons in this region in the rat [31], and have
shown that these differ in their expression of sst2A, which
is present on approximately half of the inhibitory cells in
laminae I-II [32]. Galanin- and nNOS-containing cells were
found to constitute ~60% of the sst2A-expressing neurons
in the rat, while most cells with NPY (84%) and all of those
with parvalbumin did not possess sst2A receptors [13]. The
present results demonstrate that a similar arrangement ap-
plies in the mouse, since cells with galanin and/or nNOS
again constitute ~60% of those with sst2A. However, there
are two differences between the species: firstly, the propor-
tion of NPY cells that express sst2A is somewhat higher
(24% in mouse, compared with 16% in rat [13]), and
secondly there is a significant population of cells that
contain both galanin and nNOS in the mouse. These
cells correspond to 30% of those with galanin and 56% of
those with nNOS, and they generally contain relatively
low levels of both substances.
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defined populations differ in their postsynaptic targets.
We have reported that in the rat, GABAergic axons
containing NPY preferentially innervate lamina III pro-
jection neurons that express the neurokinin 1 receptor
(NK1r) [57,58], while some of those that contain nNOS
are presynaptic to giant lamina I spinoparabrachial neu-
rons [59]. It has also been shown that the parvalbumin-
containing inhibitory interneurons, most of which are
islet cells [60], give rise to axoaxonic synapses on low-
threshold myelinated primary afferents, and these cells
are therefore presumably involved in the regulation of
tactile inputs [36]. In the case of the NPY innervation of
lamina III projection neurons, this is thought to arise from
a specific subset of NPY-containing inhibitory interneurons
[57], and a similar arrangement may also apply to the
nNOS inputs to the giant lamina I cells. If this is the
case, it would suggest that the populations defined by
these neurochemical markers are not homogeneous, but
are likely to contain further subpopulations that differ
in connections, and therefore function.
PrP-GFP cells and the nNOS and galanin populations of
inhibitory interneurons
In a series of elegant studies, Perl and colleagues have
described the physiological properties of the PrP-GFP
cells in detail [34,35,40]. These cells receive monosynaptic
primary afferent input from a class of relatively fast-
conducting C fibres, but not from Aδ afferents. They also
show specific patterns of connection to other neurons in
lamina II, since they can be reciprocally connected to islet
cells (which are also GABAergic), and can be presynaptic
(but not postsynaptic) to excitatory vertical cells [40].
These studies had already provided evidence that at least
the majority of the PrP-GFP cells were inhibitory, as GABA
immunoreactivity was seen in >80% of them [35], and they
invariably generated IPSCs in the postsynaptic cell in paired
recordings [40]. Here we show that all of these cells are in-
hibitory, since they all express sst2A, which is restricted to
GABA-immunoreactive neurons in lamina II. As stated by
Hantman et al. [35], it is likely that their failure to detect
GABA in all of the PrP-GFP cells was due to limited pene-
tration of GABA-immunostaining. This was not an issue in
the present study, as our assessment of GABA in sst2A
+ cells
was restricted to those located at the section surface.
Our immunocytochemical findings with the PrP-GFP
cells further support the neurochemical classification
scheme outlined above, since the GFP cells were entirely
contained among those inhibitory interneurons that express
sst2A [4], and within this group, they corresponded to
part of the set that contained nNOS and/or galanin.
The expression of GFP among the nNOS- and galanin-
containing inhibitory interneuron populations was not
random, as GFP cells accounted for less than a quarter ofthe galanin+/nNOS- cells, over half of the galanin-/nNOS+
cells, and the great majority (>80%) of those that contained
both nNOS and galanin. In addition, the strength of GFP
labelling tended to be higher in the nNOS-containing cells.
Although both nNOS- and galanin-containing inhibitory
interneurons express sst2A, several features indicate that in
the rat there are significant differences between them.
Glycine is often present at high levels in the nNOS cells,
but is not enriched in the galanin-containing cells [51,61].
This suggests that nNOS (but not galanin) cells may
use glycine as a co-transmitter, although it is not known
whether somatic glycine enrichment is a reliable marker
for glycinergic neurons [39]. In addition, although studies
with the transcription factor Fos indicate that both types
can respond to noxious stimuli, the nNOS cells appear far
less likely to phosphorylate extracellular signal-regulated
kinases than the galanin cells, and are less responsive
to subcutaneous injection of capsaicin [13]. However,
the present results indicate that there are common fea-
tures between nNOS and galanin populations in the
mouse, since some cells can contain both substances,
and the PrP-GFP cells include those with nNOS and/or
galanin. The Allen Brain atlas shows that although
cells with mRNA for galanin are concentrated in lam-
ina I and the outer part of lamina II in adult mice
(matching the pattern seen with immunocytochemistry),
they are more widely distributed at P4, with numerous
cells located in the inner half of lamina II and lamina III.
In contrast, expression of nNOS by neurons in laminae
I-III appears relatively late in development, with the
adult pattern only being established by the end of the
third postnatal week in the rat [62]. This raises the pos-
sibility that some inhibitory interneurons may initially
contain galanin, and then switch to nNOS expression
during postnatal development. If so, then this mechan-
ism may be more effective in the rat, whereas in the
mouse some cells continue to express both nNOS and
galanin, but with relatively low levels of each. We have
recently found that in mice lacking the transcription
factor Bhlhb5 [6], there is a substantial loss of cells that
contain nNOS and/or galanin, but not of other inhibi-
tory interneurons, (AJT, EP, D Cameron and SE Ross,
unpublished data), which supports the suggestion that
the nNOS and galanin cells are developmentally linked.
As stated above, studies with activity-dependent markers
have suggested that there are differences in the responsive-
ness of nNOS- and galanin-containing cells in the rat
superficial dorsal horn to different forms of noxious stimu-
lation [13]. Both populations seem to be activated by nox-
ious heat and subcutaneous formalin, while the galanin
(but not the nNOS) cells also respond to capsaicin. It will
therefore be of interest to determine in future studies
whether there are similar differences between these neuro-
chemical populations in the mouse, and if so, how the cells
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It will also be important to see whether there are dif-
ferences in the types of primary afferent that innervate
these populations.
Role of somatostatin
Our pharmacological results are consistent with the
anatomical finding of sst2A expression by PrP-GFP cells,
since all of the GFP neurons tested were hyperpolarised
by bath-applied somatostatin, and this effect was pre-
vented by a specific sst2 antagonist. Kim et al. [42] had
previously reported that the somatostatin-evoked hyper-
polarization of lamina II neurons involved GIRK chan-
nels, and our finding that the action of somatostatin on
the GFP cells was blocked by tertiapin-Q supports this
conclusion. Further evidence for the specificity of som-
atostatin comes from the observation that it does not
cause outward currents when applied to excitatory in-
terneurons in lamina II of the rat [14]. This consistency
between anatomical and pharmacological results is in
contrast to findings with the μ-opioid receptor MOR-1,
since MOR-1-immunoreactivity is apparently restricted
to a small proportion (~10%) of lamina II neurons [63],
whereas hyperpolarising effects of μ-opioid agonists are
seen on a far higher proportion (often more than 50%)
of neurons recorded in both lamina I and II [64-67].
Among the 5 somatostatin receptors, only sst2 appears
to be expressed by neurons in the mouse superficial
dorsal horn (Allen Brain atlas), although both sst1 and
sst2 receptors are present on small and medium-sized
(presumed nociceptive) primary afferents [68,69]. Several
previous studies have reported that sst2A receptors were
concentrated in the superficial dorsal horn [4,32,68-70],
and we have demonstrated that in both rat and mouse
these are virtually restricted to GABAergic interneurons
[4,14,32] (present study). Since somatostatin exerts an in-
hibitory action, activation of sst2A receptors on these in-
terneurons should lead to disinhibition, and is therefore
likely to increase sensory transmission, for example result-
ing in increased pain or itch [14]. In contrast, activation of
somatostatin receptors on primary afferents would sup-
press sensory transmission. It is therefore not surprising
that both pro-nociceptive [71-73] and anti-nociceptive
[74-76] effects of intrathecal somatostatin have been
reported. In fact, the main behavioural sign that was seen
following intrathecal administration of a low dose of som-
atostatin was caudally directed biting and scratching, and
although this was interpreted as increased pain [71-73], it
could also have been caused by increased itching.
The somatostatin that acts on the sst2A receptors
expressed by the GFP cells could originate from primary
afferents [77] and/or excitatory interneurons in lamina II
[78]. Nakatsuka et al. [56] were able to evoke a GIRK-
mediated hyperpolarisation in some lamina II neurons,which was thought to be caused by somatostatin, as it
was partially occluded by somatostatin-evoked cur-
rents, and was blocked by the non-specific antagonist
cyclo-somatostatin. This hyperpolarisation was con-
sistently obtained by focal electrical stimulation in the
dorsal horn, but not by dorsal root stimulation, which
suggests that the excitatory interneurons may be a
more important source of somatostatin acting on these
receptors, contributing to the intrinsic modulation of
the neuronal network in the superficial dorsal horn.
Hantman and Perl [34] have shown that all the PrP-GFP
cells tested were hyperpolarised by both norepinephrine
and serotonin, whereas varied responses were observed for
other lamina II neurons. Taken together with the present
results, this indicates that the PrP-GFP cells show consist-
ent responses to a variety of neuromodulators.Conclusions
These results demonstrate that the neurochemical organ-
isation of inhibitory interneurons in the superficial dorsal
horn of the mouse is similar to that previously reported for
the rat. The finding that all GFP+ neurons in the PrP-GFP
mouse possess sst2A receptors, and that they express nNOS
and/or galanin supports the suggestion that neurochemistry
provides a useful way of defining functional populations
among the interneurons in the superficial laminae. The
present findings, taken together with previous reports that
the PrP-GFP cells form a relatively homogeneous popula-
tion in terms of their physiological properties, suggest that
these cells may have discrete functional roles in processing
somatosensory information.
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